Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPG | P10696 | 9/20 | 0.55 |
| ▸ | ALPL | P05186 | 8/20 | 0.55 |
| ▸ | CA12 | O43570 | 3/20 | 0.53 |
| ▸ | CA1 | P00915 | 3/20 | 0.53 |
| ▸ | CA2 | P00918 | 3/20 | 0.53 |
| ▸ | CA7 | P43166 | 3/20 | 0.53 |
| ▸ | CA9 | Q16790 | 3/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.53 |
| ▸ | XDH | P47989 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | PLAA | Q9Y263 | 6/20 | 0.49 |
| ▸ | DBH | P09172 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adrenalone SCHEMBL29550997 | 1.00 | ALPG (0.55) | ALPGALPLCA12CA1CA2 | |
| Adrenalone SCHEMBL6662605 | 0.98 | ALPG (0.54) | ALPGALPLCA12CA1CA2 | |
| Adrenalone SCHEMBL28668200 | 0.96 | ALPG (0.52) | ALPGALPLCA12CA1CA2 | |
| SCHEMBL6046293 | 0.81 | ALPG (0.52) | ALPGALPLCA12CA1CA2 | |
| SCHEMBL7441728 | 0.81 | ALPG (0.52) | ALPGALPLCA12CA1CA2 | |
| SCHEMBL20310071 | 0.81 | ALPG (0.40) | ALPGALPLCA12CA1CA2 | |
| SCHEMBL14646958 | 0.81 | ALPG (0.51) | ALPGALPLCA12CA1CA2 | |
| SCHEMBL9768178 | 0.80 | KDM4E (0.53) | ALPGALPLCA12CA1CA2 | |
| SCHEMBL31419971 | 0.80 | ALPG (0.51) | ALPGALPLCA12CA1CA2 | |
| SCHEMBL29391092 | 0.80 | KDM4E (0.53) | ALPGALPLCA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1400 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118255674-B | Method for preparing isoprenaline hydrochloride | 北京均大检测科技有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-119263998-A | Production method of adrenalone hydrochloride capable of improving yield | 蚌埠丰原涂山制药有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-116082173-B | Preparation method of dopamine hydrochloride | 武汉武药制药有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-118255674-A | Method for preparing isoprenaline hydrochloride | 北京均大检测科技有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-118225915-A | Evaluation method and application of epinephrine injection | 武汉久安药物研究院有限公司 | 2024-06-21 | — | — | CN | claimed |
| US-11903992-B2 | Composition comprising lidocaine, l-carnosine and dexpanthenol | CELLIX BIO PRIVATE LIMITED (IN) | 2024-02-20 | — | — | US | claimed |
| CN-110184299-B | Factor inducing reprogramming of cells and method for inducing reprogramming of cells using the same | 中国科学院广州生物医药与健康研究院 | 2023-11-24 | — | — | CN | claimed |
| CN-113512521-B | Additive of serum-free culture medium, serum-free culture medium and application thereof | 江苏普瑞康生物医药科技有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-113583984-B | Cytochrome P450 monooxygenase CYP109B2 and application thereof | 湖北大学 | 2023-05-23 | — | — | CN | claimed |
| CN-115101204-A | Model, equipment and storage medium for quantitatively evaluating depression risk based on blood biochemical indexes | 中国科学院心理研究所 | 2022-09-23 | — | — | CN | claimed |
| WO-2003066029-A2 | PHARMACEUTICAL DOSAGE FORM FOR MUCOSAL DELIVERY | PHARMACIA CORPORATION (US) | 2003-08-14 | — | — | WO | claimed |
| WO-2003032969-A2 | ANTI-GLYCATION AGENTS FOR PREVENTING AGE-, DIABETES-, AND SMOKING-RELATED COMPLICATIONS | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2003-04-24 | — | — | WO | claimed |
| CN-1367698-A | Administration of non-oral androgenic steroids to women | WATSON PHARMACEUTICALS INC (US) | 2002-09-04 | — | — | CN | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| US-6218575-B1 | ASYMMETRIC HYDROGENATION OF N-PROTECTED ADRENALONE USING DICHLOROBIS((CYCLOOCTA-1,5-DIENE) RHODIUM (I)) AND BIDENTATE PHOSPHINE LIGAND CATALYST SYSTEM; PRECIPITATION, DEBLOCKING | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2001-04-17 | — | — | US | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| US-5047592-A | Selective hydrogenolysis process | ETHYL CORPORATION (US) | 1991-09-10 | — | — | US | claimed |
| US-4594356-A | Topical administering an adrenalone derivative | KEY PHARMACEUTICALS, INC. (US) | 1986-06-10 | — | — | US | claimed |
| US-4313956-A | Novel sypathomimetic amine prodrugs | INTERX RESEARCH CORP. (US) | 1982-02-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11903992-B2 | Composition comprising lidocaine, l-carnosine and dexpanthenol | VNN1, LPL, HMGB1 | ALPG 3733/4885ALPL 2145/4885CA12 2288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.